As the pharma services sector grows, regulators at the Department of Justice and Food and Drug Administration are putting everything from clinical trials to site management under the microscope.
McGuireWoods partner Clint Narver speaks from experience: He joined the
Continue Reading What Pharma Services Investors Should Know About Government Regulations, With Clint Narver